Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home >Pharma China Archives > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Product/R&D News
Galectin Therapeutics To Be Granted Chinese Patent for Its Lead C... 9/13/2017
BeiGene Presents Preliminary Phase 1 Data for BGB-A317 in Multipl... 9/11/2017
BeiGene Presents Preliminary Phase 1/2 Clinical Data on PARP Inhi... 9/9/2017
Yisheng Biopharma Announces Breakthrough Results on Immuno-oncolo... 8/30/2017
Chi-Med Initiates a Phase I Trial of Selective PI3Kδ Inhibitor i... 8/30/2017
NIH Quietly Proposes to Grant Salubris Rights to A Portfolio of L... 8/8/2017
Tyme Receives Notice of Allowance of Patent for SM-88 in China 8/4/2017
DelMar Pharma Cleared to Initiate Phase 2 Clinical Trial in Newly... 7/26/2017
SillaJen and Lee's Pharma Approved to Commence Phase III Trial of... 7/20/2017
China Accepts Propanc Biopharma's Patent Application for Novel An... 7/20/2017
Ascentage Granted IND Approval for Bcl-2/Bcl-XL inhibitor APG-125... 7/18/2017
CFDA Approves Clinical Trial of CStone's Fully Human, Full-length... 7/18/2017
Snapshot of Domestically R&D and IND Filings of PD-1/PD-L... 7/14/2017
CDE-Accepted Drug Registration Applications Up in the First Half 7/12/2017
CFDA Approves BeyondSpring's Second Global Plinabulin Trial in Ch... 7/10/2017
Athenex Submits Chinese IND for Oral Formulation of Paclitaxel 7/7/2017
BeiGene Initiates Pivotal Trial of PD-1 Antibody BGB-A317 in Chin... 7/5/2017
BeiGene Presents Preliminary Phase 1 Data on HCC Drug Candidate B... 6/30/2017
New Chinese Study Advances DNA Vaccine Against Dengue Virus (free) 6/30/2017
AstraZeneca, Chi-Med Launch Savolitinib Phase III Trial 6/29/2017
Eisai Temporarily Withdraws NDA for Anticancer Halaven in China 6/29/2017
Chi-Med Initiates a Phase I/II Clinical Trial of Novel FGFR Inhib... 6/22/2017
BeiGene Presents Phase 1 Data on BTK Inhibitor BGB-3111 Combined ... 6/16/2017
Six Agencies Issue Joint Special 13th FYP for Healthcare Industry... 6/16/2017
China Investigates Claims of Academic Fraud Relating to Cancer Re... 6/15/2017
Chi-Med Files Chinese NDA for Anticancer Fruquintinib 6/12/2017
Chinese Experimental Cell Therapy Found Effective Against Multipl... 6/5/2017
Xcovery's Lung Cancer New Drug Approved for International Multice... 6/2/2017
TaiGen Announces NDA Submission for Taigexyn IV Formulation to th... 5/31/2017
Hengrui's Breast Cancer Candidate Shows Promise in an Early Trial... 5/26/2017
Page:1/24    Total number of articles:708  :[1][2][3][4][5][>>][End]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links